Literature DB >> 16792577

Specific oral tolerance induction in food allergy.

B Niggemann1, U Staden, C Rolinck-Werninghaus, K Beyer.   

Abstract

Specific oral tolerance in food allergy can be induced by oral administration of the offending food, starting with very low dosages, gradually increasing the daily dosage up to an amount equivalent to a usually relevant dose for daily intake, followed up by a daily maintenance dose. Unfortunately, the body of scientific evidence concerning specific oral tolerance induction (SOTI) is still rather poor. Following a couple of case reports, only a few studies on a limited number of patients including different allergens are available. So far, no placebo-controlled, long-term study has been published. Concerning the underlying immunological mechanism, a limited number of studies have reported on changes in antibody production, and more recently on the role of different T-cell populations. The individual pattern of clinical reaction during SOTI seems to vary considerably between patients and from allergen to allergen. Arguments in favour of SOTI are the safety for an inadvertent intake of the offending food and the increased quality of life. Arguments against SOTI are the necessity for a regular intake and possible long-term compliance problems. Indications to consider SOTI in the future might be (i) importance of the incriminated food for the individual nutritional regimen, (ii) avoidance of the corresponding food cannot be assured and (iii) persistent severe food allergy. However, before SOTI can be recommended for the daily praxis, more studies are warranted to clarify whether certain patients may profit from SOTI and to understand the underlying mechanism.

Entities:  

Mesh:

Year:  2006        PMID: 16792577     DOI: 10.1111/j.1398-9995.2006.01066.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  9 in total

1.  Are we getting enough allergens?

Authors:  Allan Linneberg
Journal:  Int Arch Allergy Immunol       Date:  2008-06-03       Impact factor: 2.749

Review 2.  New perspectives for use of native and engineered recombinant food proteins in treatment of food allergy.

Authors:  Anna Nowak-Wegrzyn
Journal:  Immunol Allergy Clin North Am       Date:  2007-02       Impact factor: 3.479

Review 3.  Induced and natural regulatory T cells in the development of inflammatory bowel disease.

Authors:  Christopher G Mayne; Calvin B Williams
Journal:  Inflamm Bowel Dis       Date:  2013-07       Impact factor: 5.325

4.  Food allergy from an avoidance to a proactive approach: a bridge too far?

Authors:  Julie Wang; Alessandro Fiocchi
Journal:  Curr Opin Allergy Clin Immunol       Date:  2012-06

5.  Safety of a peanut oral immunotherapy protocol in children with peanut allergy.

Authors:  Alison M Hofmann; Amy M Scurlock; Stacie M Jones; Kricia P Palmer; Yuliya Lokhnygina; Pamela H Steele; Janet Kamilaris; A Wesley Burks
Journal:  J Allergy Clin Immunol       Date:  2009-05-27       Impact factor: 10.793

6.  Specific oral desensitization in children with IgE-mediated cow's milk allergy. Evolution in one year.

Authors:  Montserrat Alvaro; Ma Teresa Giner; Marta Vázquez; Jaime Lozano; Olga Domínguez; Mónica Piquer; Marcia Días; Rosa Jiménez; Ma Anunciación Martín; Laia Alsina; Ana Ma Plaza
Journal:  Eur J Pediatr       Date:  2012-05-11       Impact factor: 3.183

7.  Wine allergy in a wine-growing district: tolerance induction in a patient with allergy to grape lipid-transfer protein.

Authors:  Susanne G Schäd; Jiri Trcka; Iris Lauer; Stephan Scheurer; Axel Trautmann
Journal:  World Allergy Organ J       Date:  2010-01       Impact factor: 4.084

8.  Implementing specific oral tolerance induction to milk into routine clinical practice: experience from first 50 patients.

Authors:  David Luyt; Kristian Bravin; Jessica Luyt
Journal:  J Asthma Allergy       Date:  2014-01-28

Review 9.  Oral Immunotherapy in Food Allergy: A Critical Pediatric Perspective.

Authors:  Aysegul Akarsu; Giulia Brindisi; Alessandro Fiocchi; Anna Maria Zicari; Stefania Arasi
Journal:  Front Pediatr       Date:  2022-02-22       Impact factor: 3.418

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.